MEDICOX Co., Ltd. Stock

Equities

A054180

KR7054180005

Shipbuilding

End-of-day quote Korea S.E. 06:00:00 2024-07-02 pm EDT 5-day change 1st Jan Change
539 KRW -29.91% Intraday chart for MEDICOX Co., Ltd. +23.91% -51.22%
Sales 2022 21.82B 15.82M Sales 2023 26.88B 19.48M Capitalization 35.78B 25.94M
Net income 2022 -42.62B -30.9M Net income 2023 -32.38B -23.47M EV / Sales 2022 3.53 x
Net cash position 2022 6.62B 4.8M Net cash position 2023 1.17B 848K EV / Sales 2023 1.29 x
P/E ratio 2022
-1.67 x
P/E ratio 2023
-0.99 x
Employees 83
Yield 2022 *
-
Yield 2023
-
Free-Float 70.67%
More Fundamentals * Assessed data
Dynamic Chart
MEDICOX Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
MEDICOX Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MEDICOX Co., Ltd. announced that it expects to receive KRW 24.99999935 billion in funding CI
ASTI Unit's Affiliate to Form Battery JV with South Korea's Medicox MT
Eocell Limited Enters into Non-Binding Memorandum of Understanding for A Joint Venture to Develop A Lithium-Ion Battery Manufacturing Facility and Battery Engineering Service Agreement with Medicox Co. LtdSI CI
MEDICOX Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
MEDICOX Co., Ltd. announced that it expects to receive KRW 9.999998976 billion in funding from Needs Investment and other investors CI
MEDICOX Co., Ltd. cancelled the transaction announced on December 27, 2022 CI
MEDICOX Co., Ltd. cancelled the transaction announced on February 7, 2023 CI
MEDICOX Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
MEDICOX Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
MEDICOX Co., Ltd. announced that it has received KRW 3.99999852 billion in funding from Connect Investment Co., Ltd., Sonid Inc. CI
MEDICOX Co., Ltd. announced that it has received KRW 3.99999852 billion in funding CI
MEDICOX Co., Ltd. announced that it has received KRW 10 billion in funding from L-Bio Production Activation Equity No. 1 CI
MEDICOX Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day-29.91%
1 week+23.91%
Current month+2.86%
1 month-4.94%
3 months-29.73%
6 months-51.00%
Current year-51.22%
More quotes
1 week
442.00
Extreme 442
806.00
1 month
417.00
Extreme 417
806.00
Current year
417.00
Extreme 417
1 132.00
1 year
417.00
Extreme 417
2 160.00
3 years
255.00
Extreme 255
9 825.00
5 years
255.00
Extreme 255
18 700.00
10 years
255.00
Extreme 255
35 750.00
More quotes
Managers TitleAgeSince
Director/Board Member 54 19-02-18
Comptroller/Controller/Auditor 37 -
Comptroller/Controller/Auditor 56 -
Members of the board TitleAgeSince
Director/Board Member 55 Feb. 28
Director/Board Member 50 -
Director/Board Member 52 -
More insiders
Date Price Change Volume
24-07-03 539 -29.91% 11,121,180
24-07-02 769 +21.10% 9,465,199
24-07-01 635 +21.18% 6,199,967
24-06-28 524 +12.21% 1,235,404
24-06-27 467 +7.36% 1,131,019

End-of-day quote Korea S.E., July 02, 2024

More quotes
Medicox Co Ltd, formerly ChoongAng Ocean Co Ltd, is a Korea-based company specialized in the manufacture and sale of shipbuilding materials. The Company operates its business through two segments. The Shipbuilding Equipment segment manufactures blocks of parts which require special manufacturing conditions, such as bows, sterns, propeller bosses and engine rooms of mega ships. The Motor and Generator segment is engaged in custom production of electric motors and generators and custom production of electric motors for railway vehicles.
More about the company
  1. Stock Market
  2. Equities
  3. A054180 Stock